ED Coding & Reimbursement Alert - 2007 Issue 21
COMPLIANCE: Protect Patients By Noting These Part D Requirements
Subscribe or sign in to view the full article.
Article Overview
This compliance-focused article covers Medicare Part D formulary clarifications discussed in the CMS final call letter. It addresses coverage expectations for certain protected drug classes, CMS review of vaccines in formularies, and the status of separate operational guidance on vaccine administration reimbursement under Part D. The content is aimed at readers tracking Medicare Part D policy changes, formulary oversight, and related reimbursement guidance.
Why This Topic Matters
These updates can affect whether beneficiaries can access covered medications and vaccines under Part D, and they matter to plans, coders, compliance staff, and billing professionals monitoring CMS policy changes.
What You Will Learn
- How CMS is addressing formulary-related changes under Medicare Part D
- Which broad drug coverage categories are being monitored for 2008
- How vaccine coverage review is being handled in formularies
- Why vaccine administration reimbursement guidance remains pending
Who Should Read This
- Medical coders
- Compliance professionals
- Health plan administrators
- Pharmacy benefit managers
- Billing staff
- Medicare policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com